pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Simvastatin
drug
save

simvastatin

Marketedupdated 3mo ago
by Yiling Pharmaceutical Ltd
Approved
community read0 votes

🐶 often sniffed alongside

top 5
  • companyGlenmark Pharmaceuticals Ltd6 co-mentions · 1 sources
  • drugFlolipid5 co-mentions · 2 sources
  • tagRecall2 co-mentions · 1 sources
  • drugezetimibe2 co-mentions · 1 sources
  • companyDow University of Health Sciences1 co-mentions · 1 sources

indications

investigational
Hyperlipidemia

all catalysts(1)

phase 2 completion · 1
Apr 30, 2026
phase 2 completion
4mo ago
Dow University of Health Sciences — simvastatin (Phase II Trial Completion)
simvastatin
→

Trials studying simvastatin

  • phase3Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysiscompletedn=260
  • phase1A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjectscompletedn=28
  • phase1Study to Assess the Effect of AZD9291 on the Blood Levels of Simvastatin in Patients With EGFRm+ NSCLCcompletedn=52
  • phase1A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participantscompletedn=49
  • —Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russiarecruitingn=2,382
  • phase4An Open-label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatincompletedn=17
  • phase3A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)completedn=1,398
  • phase3A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)completedn=611
more trials →

Patent cliff

source: FDA Orange Book
first barrier falls
Oct 11, 2026
54 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (16)

  • Feb 23, 2030formulationUS 95972893.5y
  • Feb 23, 2030formulationUS 95972893.5y
  • Apr 26, 2027formulationUS 10300041251d
  • Apr 26, 2027formulationUS 10300041251d
  • Oct 11, 2026patentUS 7326708*PED54d
  • Oct 11, 2026patentUS 7326708*PED54d
  • Oct 11, 2026patentUS 7326708*PED54d
  • Oct 11, 2026patentUS 7326708*PED54d
  • Oct 11, 2026patentUS 7326708*PED54d
  • Oct 11, 2026patentUS 7326708*PED54d
  • Apr 11, 2026compositionUS 7326708
  • Apr 11, 2026compositionUS 7326708
  • Apr 11, 2026compositionUS 7326708
  • Apr 11, 2026compositionUS 7326708
  • Apr 11, 2026compositionUS 7326708
  • Apr 11, 2026compositionUS 7326708

News(0)

no news has mentioned this drug yet

brand
Simvastatin
generic
simvastatin
indication
Cardiovascular Risk Factors
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 19m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?